Demons of density do higher-density environments put people at greater risk of contagious disease?

Ellen, Ingrid Gould; Howland, Renata E.; Glied, Sherry

doi:10.1016/j.jhe.2022.101905

Cited by 6 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Subgroup analyses for the primary outcome were conducted, stratified by insurance, citizenship, and socioeconomic status. Socioeconomic status was determined by the patient's zip code and subsequently categorized as either above or below the mean poverty level in New York City, using data sourced from the NYU Furman Center's CoreData.nyc 14 . Normotensive shock was defined as patients with systolic blood pressure (SBP) ≥90 mmHg in the absence of vasopressor support with preprocedural invasive measures of CI ≤2.2 L/min/m 2 and clinical evidence of hypoperfusion (i.e., elevated lactate, oliguria) 15 .…”

Section: Methodsmentioning

confidence: 99%

Percutaneous mechanical thrombectomy in acute pulmonary embolism: Outcomes from a safety‐net hospital

Zhang,

Alviar,

Yuriditsky

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

BackgroundOur study aims to present clinical outcomes of mechanical thrombectomy (MT) in a safety‐net hospital.MethodsThis is a retrospective study of intermediate or high‐risk pulmonary embolism (PE) patients who underwent MT between October 2020 and May 2023. The primary outcome was 30‐day mortality.ResultsAmong 61 patients (mean age 57.6 years, 47% women, 57% Black) analyzed, 12 (19.7%) were classified as high‐risk PE, and 49 (80.3%) were intermediate‐risk PE. Of these patients, 62.3% had Medicaid or were uninsured, 50.8% lived in a high poverty zip code. The prevalence of normotensive shock in intermediate‐risk PE patients was 62%. Immediate hemodynamic improvements included 7.4 mmHg mean drop in mean pulmonary artery pressure (−21.7%, p < 0.001) and 93% had normalization of their cardiac index postprocedure. Thirty‐day mortality for the entire cohort was 5% (3 patients) and 0% when restricted to the intermediate‐risk group. All 3 patients who died at 30 days presented with cardiac arrest. There were no differences in short‐term mortality based on race, insurance type, citizenship status, or socioeconomic status. All‐cause mortality at most recent follow up was 13.1% (mean follow up time of 13.4 ± 8.5 months).ConclusionWe extend the findings from prior studies that MT demonstrates a favorable safety profile with immediate improvement in hemodynamics and a low 30‐day mortality in patients with acute PE, holding true even with relatively higher risk and more vulnerable population within a safety‐net hospital.

show abstract

Section: Methodsmentioning

confidence: 99%